Annual report pursuant to Section 13 and 15(d)

Share-Based Compensation

v3.23.1
Share-Based Compensation
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Share-based Compensation

NOTE 9 – SHARE-BASED COMPENSATION

Global Incentive Plan

On May 31, 2022, the shareholders of the Company approved the Company’s Board of Directors proposal to increase the Company’s Global Incentive Plan (the “Plan”) by 6,300,000 shares, thus bringing the total number of stock options and restricted stock units (“RSUs”) that may be issued pursuant to the Plan to 7,803,421. During the year ended December 31, 2022, the Board of Directors of the Company approved the issuance of 2,370,576 stock options and 1,427,404 RSUs. In addition, during the year ended December 31, 2022, 115,827 stock options and 140,614 RSU's were either exercised or canceled respectively. As of December 31, 2022, the remaining number of underlying shares available for future issuances under the Plan is 2,699,263.

Under the terms of the Plan, on the grant date, the Board of Directors determines the vesting schedule of each stock option and RSUs on an individual basis. All stock options expire the earlier of (1) ten years from the date of the grant, (2) May 31, 2031 or (3) 90 days after the termination of employment of the grantee.

Stock Options

The fair value of options and share awards granted under the stock option plan during the year ended December 31, 2022 and 2021 was estimated at the date of grant using the Black-Scholes option pricing model and the following assumptions for grants:

 

 

2022

 

 

2021

 

Risk-free interest rates

 

 

3.61

%

 

 

0.91

%

Expected life

 

5 years

 

 

5 years

 

Expected volatility

 

 

41.00

%

 

 

40.81

%

Expected dividend yield

 

 

0.00

%

 

 

0.00

%

 

The following table summarizes the stock option activity:

 

 

 

 

 

 

 

Weighted Average

 

 

Aggregate

 

 

 

Number of

 

 

Weighted Average

 

 

Remaining

 

 

Intrinsic

 

 

 

Options

 

 

Exercise Price

 

 

Contractual Term

 

 

Value

 

Balance at January 1, 2022

 

 

1,472,988

 

 

$

1.92

 

 

 

8.98

 

 

$

3,616,248

 

Granted

 

 

2,370,576

 

 

 

1.11

 

 

 

 

 

Forfeited/Cancelled

 

 

(26,196

)

 

 

0.002

 

 

 

 

 

Exercised

 

 

(89,631

)

 

 

0.002

 

 

 

 

 

Balance at December 31, 2022

 

 

3,727,737

 

 

 

1.47

 

 

 

8.91

 

 

$

203,295

 

Exercisable at December 31, 2022

 

 

1,697,083

 

 

$

1.54

 

 

 

8.74

 

 

$

130,188

 

The following table summarizes the Company’s non-vested stock options activity:

 

 

 

Weighted-Average

 

 

Non-vested Options

 

 

Grant Date Fair

 

 

Outstanding

 

 

Value

 

At January 1, 2022

 

 

1,058,235

 

 

$

0.95

 

Options granted

 

 

2,370,576

 

 

 

0.46

 

Options forfeited/cancelled

 

 

(26,196

)

 

 

1.97

 

Options exercised

 

 

(89,631

)

 

 

1.28

 

Options vested

 

 

(1,282,330

)

 

 

0.97

 

At December 31, 2022

 

 

2,030,654

 

 

$

0.66

 

 

 

Table of Contents

NOTE 9 – SHARE-BASED COMPENSATION (CONTINUED)

For the years ended December 31, 2022 and 2021, the Company recognized $828,860 and $394,311 of stock compensation expense relating to stock options, respectively. As of December 31, 2022, there was $1,301,599 of unrecognized stock compensation expense related to non-vested share-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of approximately two years.

Restricted Stock Awards

In July 2019, the Board of Directors authorized grants of restricted stock awards (“RSAs”) through a restricted stock award purchase agreement to certain founders, consultants, and advisors of the Company. Certain grants to the Company’s founders were fully vested at the date of incorporation, other grants vest over a four-year period on each anniversary of the grant date, based on continued employment, and other grants vested based on various milestones. The shares of common stock underlying the RSAs are issued upon grant.

The following table summarizes the restricted stock awards activity:

 

 

 

 

Weighted-Average

 

 

Restricted Stock

 

 

Grant Date Fair Value

 

 

 

Awards

 

 

Per Share

 

Outstanding at January 1, 2022

 

 

708,615

 

 

$

1.42

 

Granted

 

 

 

 

 

 

Forfeited/cancelled

 

 

 

 

 

 

Vested

 

 

(485,677

)

 

 

1.44

 

Outstanding at December 31, 2022

 

 

222,938

 

 

$

1.48

 

 

 

 

 

 

 

 

For the years ended December 31, 2022 and 2021, the Company recognized $1,301,599 and $836,481 of stock compensation expense relating to RSAs, respectively. As of December 31, 2022, there was $312,631 of unrecognized compensation expense related to unvested restricted share awards that is expected to be recognized over a weighted-average period of approximately 1 year.

Restricted Stock Units

On June 14, 2022, the Board of Directors of the Company authorized the grant of 1,427,404 RSU's of which 1,346,154 were granted to an officer who joined the Company in February 2022. Of the RSUs granted to the officer, 192,308 vested immediately and the balance of 1,153,846 will vest in equal quarterly installments through February 28, 2023. Under the terms of the officer’s employment agreement, the Company also agreed to guarantee the minimum value of the RSUs on their vesting dates. The Company accrued an amount of $74,359 in accrued expenses in the consolidated balance sheets, reflecting this minimum value obligation as of December 31, 2022.

In addition, the Company agreed to issue to the officer a one-time grant of fully vested shares of the Company’s common stock with a fair market value of $250,000 as a signing bonus to be provided following the twelve-month anniversary of the officer’s start date with the Company. Included in accrued expenses as of December 31, 2022 in the consolidated balance sheets is an amount of $250,000 representing the full value of the signing bonus.

On November 23, 2022, the Company canceled 140,614 RSUs held by an officer of the Company in exchange for a cash bonus of $147,645. These RSUs were due to vest on November 28, 2022.

The following table summarizes the restricted stock units activity:

 

 

 

 

 

 

 

 

Restricted Stock

 

 

 

 

 

 

Units

 

 

Value

 

Outstanding at January 1, 2022

 

 

 

 

$

 

Granted

 

 

1,427,404

 

 

 

1.11

 

Forfeited/cancelled

 

 

(140,614

)

 

 

1.11

 

Vested

 

 

(994,963

)

 

 

1.11

 

Outstanding at December 31, 2022

 

 

291,827

 

 

$

1.11

 

For the year ended December 31, 2022 and 2021, the Company recognized $1,406,548 and $0 of stock compensation expense relating to RSUs, respectively. As of December 31, 2022, there was of unrecognized compensation expense related to unvested RSUs that is expected to be recognized over a period of two months for one employee of $333,332 and four years for another employee of $39,313.